Back to top

Tale of the Tape

Read Full ArticleHide Full Article

NuVasive, Inc.’s (NUVA - Free Report) share price has entered into oversold territory with a stochastic value of 10.4696. The Zacks Consensus Estimate on the company’s earnings for year ending December 2012 increased by a cent over the past month to 55 cents per share. NuVasive, Inc. is a Zacks Rank #1 (“Strong Buy”) company.

 




In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


NuVasive, Inc. (NUVA) - free report >>